Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
Open Access
- 15 August 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 166, 115336
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82004281)
- China Postdoctoral Science Foundation (2021M691986)
- China Postdoctoral Science Foundation (2021T140427)
- Taishan Scholar Foundation of Shandong Province
- China Academy of Space Technology (2021-QNRC2-B25)
- Shandong Provincial Postdoctoral Science Foundation (2021)
This publication has 175 references indexed in Scilit:
- SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancerOncoImmunology, 2013
- An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in CancerCancer Research, 2012
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumorsJournal of Clinical Investigation, 2012
- Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancerLung Cancer, 2010
- Tumors induce the formation of suppressor endothelial cells in vivoCancer Immunology, Immunotherapy, 2009
- IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancerInternational Journal of Cancer, 2009
- VEGF-A and the Induction of Pathological AngiogenesisAnnual Review of Pathology: Mechanisms of Disease, 2007
- CCL19 reduces tumour burden in a model of advanced lung cancerBritish Journal of Cancer, 2006
- Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung CancerClinical Cancer Research, 2005